These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11698067)

  • 1. Intracerebroventricular administration of a glucocorticoid receptor antagonist enhances the cardiovascular responses to brief restraint stress.
    Van Acker SA; Fluttert MF; Sibug RM; De Kloet ER
    Eur J Pharmacol; 2001 Oct; 430(1):87-91. PubMed ID: 11698067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid antagonist inhibits stress-induced blood pressure response after repeated daily warming.
    Van den Berg DT; de Jong W; de Kloet ER
    Am J Physiol; 1994 Dec; 267(6 Pt 1):E921-6. PubMed ID: 7810635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint.
    Calvo N; Volosin M
    Neuroendocrinology; 2001 Apr; 73(4):261-71. PubMed ID: 11340340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
    Ratka A; Sutanto W; Bloemers M; de Kloet ER
    Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats.
    Van den Berg DT; de Kloet ER; de Jong W
    Am J Physiol; 1994 Dec; 267(6 Pt 1):E927-33. PubMed ID: 7810636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze.
    Korte SM; de Boer SF; de Kloet ER; Bohus B
    Psychoneuroendocrinology; 1995; 20(4):385-94. PubMed ID: 8532822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
    Spencer RL; Kim PJ; Kalman BA; Cole MA
    Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockage of glucocorticoid, but not mineralocorticoid receptors prevents the persistent increase in circulating basal corticosterone concentrations following stress in the rat.
    Moldow RL; Beck KD; Weaver S; Servatius RJ
    Neurosci Lett; 2005 Feb; 374(1):25-8. PubMed ID: 15631890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus.
    van Haarst AD; Oitzl MS; de Kloet ER
    Neurochem Res; 1997 Nov; 22(11):1323-8. PubMed ID: 9355104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
    van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
    Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of sodium intake on the cardiovascular and renal effects of brain mineralocorticoid receptor blockade in normotensive rats.
    Rahmouni K; Barthelmebs M; Grima M; Imbs JL; De Jong W
    J Hypertens; 2002 Sep; 20(9):1829-34. PubMed ID: 12195126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mineralocorticoid and glucocorticoid receptor blockade on hypothalamic-pituitary-adrenal function in female rats prenatally exposed to ethanol.
    Glavas MM; Yu WK; Weinberg J
    Alcohol Clin Exp Res; 2006 Nov; 30(11):1916-24. PubMed ID: 17067357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and renal effects of central administration of a mineralocorticoid receptor antagonist in conscious female rats.
    Rahmouni K; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 1999 Dec; 385(2-3):199-202. PubMed ID: 10607876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid and glucocorticoid receptor antagonists in animal models of anxiety.
    Korte SM; Korte-Bouws GA; Koob GF; De Kloet ER; Bohus B
    Pharmacol Biochem Behav; 1996 May; 54(1):261-7. PubMed ID: 8728567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
    Rickard AJ; Funder JW; Morgan J; Fuller PJ; Young MJ
    Endocrinology; 2007 Oct; 148(10):4829-35. PubMed ID: 17640982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of mineralocorticoid and glucocorticoid receptors reverses stress-induced motor impairments.
    Jadavji NM; Supina RD; Metz GA
    Neuroendocrinology; 2011; 94(4):278-90. PubMed ID: 22024815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief neck restraint stress enhances long-term potentiation and suppresses long-term depression in the dentate gyrus of the mouse.
    Spyrka J; Danielewicz J; Hess G
    Brain Res Bull; 2011 Jul; 85(6):363-7. PubMed ID: 21624439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
    Savci V; Cavun S; Goktalay G; Ulus IH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.